166 related articles for article (PubMed ID: 12566365)
1. Effects of AGI-1067 and probucol after percutaneous coronary interventions.
Tardif JC; Grégoire J; Schwartz L; Title L; Laramée L; Reeves F; Lespérance J; Bourassa MG; L'Allier PL; Glass M; Lambert J; Guertin MC;
Circulation; 2003 Feb; 107(4):552-8. PubMed ID: 12566365
[TBL] [Abstract][Full Text] [Related]
2. Clinical results with AGI-1067: a novel antioxidant vascular protectant.
Tardif JC
Am J Cardiol; 2003 Feb; 91(3A):41A-49A. PubMed ID: 12645643
[TBL] [Abstract][Full Text] [Related]
3. Prevention of restenosis with antioxidants: mechanisms and implications.
Tardif JC; Grégoire J; L'Allier PL
Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
Curr Opin Lipidol; 2003 Dec; 14(6):615-20. PubMed ID: 14624139
[TBL] [Abstract][Full Text] [Related]
5. Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth.
Doggrell SA
Expert Opin Investig Drugs; 2003 Nov; 12(11):1855-9. PubMed ID: 14585060
[TBL] [Abstract][Full Text] [Related]
6. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
[TBL] [Abstract][Full Text] [Related]
7. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.
Côté G; Tardif JC; Lespérance J; Lambert J; Bourassa M; Bonan R; Gosselin G; Joyal M; Tanguay JF; Nattel S; Gallo R; Crépeau J
Circulation; 1999 Jan 5-12; 99(1):30-5. PubMed ID: 9884376
[TBL] [Abstract][Full Text] [Related]
8. Prevention of restenosis after angioplasty in small coronary arteries with probucol.
Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC
Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236
[TBL] [Abstract][Full Text] [Related]
9. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
[TBL] [Abstract][Full Text] [Related]
10. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
[TBL] [Abstract][Full Text] [Related]
12. Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial.
Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Anderson TJ; Reeves F; Title LM; Schampaert E; LeMay M; Lespérance J; Scott R; Guertin MC; Brennan ML; Hazen SL; Bertrand OF;
Atherosclerosis; 2008 Mar; 197(1):480-6. PubMed ID: 17214993
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants and atherosclerosis: emerging drug therapies.
Tardif JC
Curr Atheroscler Rep; 2005 Feb; 7(1):71-7. PubMed ID: 15683606
[TBL] [Abstract][Full Text] [Related]
14. Vascular protectants for the treatment of atherosclerosis.
Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):385-92. PubMed ID: 15030266
[TBL] [Abstract][Full Text] [Related]
15. AGI-1067: a novel vascular protectant for prevention of restenosis.
Franks AM; Gardner SF
Ann Pharmacother; 2006 Jan; 40(1):66-73. PubMed ID: 16303986
[TBL] [Abstract][Full Text] [Related]
16. Effects of plaque composition on vascular remodelling after angioplasty in the MultiVitamins and Probucol (MVP) trial.
Lee HS; Tardif JC; Harel F; Côté G; Joyal M; Gosselin G; L'Allier PL; Doucet S; de Guise P; Lespérance J; Grégoire JC; Couturier A
Can J Cardiol; 2002 Mar; 18(3):271-5. PubMed ID: 11907616
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants: the good, the bad and the ugly.
Tardif JC
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):61B-65B. PubMed ID: 16498514
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
[TBL] [Abstract][Full Text] [Related]
19. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study.
Alfonso F; García P; Fleites H; Pimentel G; Sabaté M; Hernández R; Escaned J; Bañuelos C; Pérez-Vizcayno MJ; Moreno R; Macaya C
Am Heart J; 2005 Feb; 149(2):e1-8. PubMed ID: 15846250
[TBL] [Abstract][Full Text] [Related]
20. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis.
Schneider JE; Berk BC; Gravanis MB; Santoian EC; Cipolla GD; Tarazona N; Lassegue B; King SB
Circulation; 1993 Aug; 88(2):628-37. PubMed ID: 8339427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
